Connor, Clark & Lunn Investment Management Ltd. - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 60 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$86,248
-42.7%
21,835
-54.6%
0.00%
-100.0%
Q2 2023$150,472
-20.6%
48,074
+14.9%
0.00%0.0%
Q1 2023$189,567
+22.4%
41,847
+11.6%
0.00%0.0%
Q4 2022$154,813
+268.6%
37,485
+186.9%
0.00%
Q3 2022$42,00013,0650.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 1,515,148$22,136,0004.43%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,144,539$75,162,0001.58%
SILVERARC CAPITAL MANAGEMENT, LLC 191,945$2,804,0001.53%
Atlas Venture Advisors, Inc. 292,184$4,269,0000.79%
Sio Capital Management, LLC 187,223$2,735,0000.56%
Vivo Capital, LLC 799,662$11,683,0000.41%
Altium Capital Management LP 93,261$1,363,0000.38%
RA Capital Management 1,515,151$22,136,0000.33%
Logos Global Management LP 230,000$3,360,0000.33%
DAFNA Capital Management LLC 81,432$1,190,0000.28%
View complete list of LARIMAR THERAPEUTICS INC shareholders